Colorescience® announces the launch of PEP UP™ Collagen Renewal Face & Neck Treatment, a powerful clinically-tested treatment that trains skin to build its own healthy collagen to defend against the visible signs of aging.
Colorescience®, leading dermatologist-recommended skincare and cosmetics company, is proud to introduce its latest innovation, the Colorescience Total Eye™ Restore Regimen, a comprehensive, 24-hour solution that immediately addresses multiple eye area concerns and provides long-term improvement.
Philadelphia Business Journal lists Adele Oliva as one of twelve women who are having an impact on bioscience
The announcement was made today, at the 15th annual Maui Derm Conference, that Impoyz Cream demonstrated efficacy early, with 14.2% of Impoyz patients achieving treatment success at day 8 versus 1.6% in the vehicle group. Treatment success was achieved when subjects received a “clear” or “almost clear” assessment, marking at least a 2-grade improvement from …
Biocoat, Inc. announced today that Steven Bell has joined the company as Chief Financial Officer (CFO). Based in Horsham, PA, Biocoat develops and licenses biomaterial coatings for interventional medical devices that are custom engineered to meet specific clinical design parameters.
Biocoat, Inc., (Biocoat) a 27-year old privately held company, announced today that it has been acquired by 1315 Capital, a Philadelphia-based healthcare investment firm that provides expansion and growth capital to commercial-stage healthcare services, medical technology, and specialty pharmaceutical companies.
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has completed the acquisition of the parent company of Genoptix, Inc. for $125 million in cash, as adjusted by working capital and other adjustments, and 1 million shares of NeoGenomics common stock. Genoptix is a leading clinical oncology laboratory, …
Encore Dermatology, Inc. today announced the publication of a Phase 2, open-label study in SKIN The Journal of Cutaneous Medicine. Subjects treated with Impoyz (clobetasol propionate) Cream, 0.025% showed significantly lower mean post-treatment clobetasol propionate plasma concentrations versus the subjects treated with Temovate® (clobetasol propionate) Cream, 0.05% (56.3 vs 152.5 pg/mL, P=0.014).
Innovative Health, a national leader in medical device reprocessing for the cardiology sector, announced it has received FDA clearances to reprocess the Advisor FL Circular Mapping Catheter, Medtronic’s Torqr™ and Marinr™, and Biosense Webster’s DECANAV. Three of these clearances were received within the last month alone.
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has entered into a definitive agreement to acquire Genoptix, Inc. for $125 million in cash and 1 million shares of NeoGenomics common stock. Genoptix is a leading clinical oncology laboratory, specializing in hematology and solid tumor testing, with an …